Peter Dreger started his scientific career at the University of Kiel, Germany. In 2005 he accepted the position of Professor and Head of the Division of Stem Cell Transplantation at the University of Heidelberg, where he is also running the clinical CLL and CAR T-cell programs.
Peter Dreger is a founding member of the German CLL Study Group and he has been a panel member since then. He served as chairman of the CLL subcommittee of the EBMT Chronic Leukemia WP from 2005 to 2010 and as chairman of the EBMT Lymphoma Working Party from 2010 to 2016. He is a member of the Board of the German Society for Hematology and Oncology and founding member and Speaker of the Cellular Therapy Working Group of the German Lymphoma Alliance (GLA). He is also the current Speaker of the German Working Group for Hematopoietic Stem Cell Transplantation and Cellular Therapy (DAG-HSZT, formerly DAG-KBT).
EM-61407 - Date of preparation: June 2021